Polarean Imaging’s XENOVIEW 3T coil passes Philips compatibility testing

Polarean Imaging (PLLWF) announces that its FDA-cleared XENOVIEW 3T Chest Coil has completed compatibility testing conducted by Philips and is now confirmed for use with Philips’ latest 3T MRI platforms. Following extensive validation by Philips, the XENOVIEW 3T Chest Coil is now confirmed for integration with Philips MRI systems starting in early 2026, including 3.0T platforms such as the MR 7700 and Ingenia Elition X, along with their associated upgrade pathways. Building on Philips’ introduction of Xenon MRI compatibility in 2022 with the MR 7700, the addition of the Polarean XENOVIEW 3T Chest Coil expands access to advanced pulmonary imaging and supports a new era of functional lung assessment. This confirmation, building on the coil’s FDA clearance in 2024, positions the technology for rapid clinical adoption and revenue generation. The XENOVIEW 3T Chest Coil enables healthcare providers to seamlessly adopt advanced functional lung ventilation imaging, supporting broader clinical adoption and advancing the Company’s commitment to innovation in pulmonary imaging.